Home
University of Bergen

Centre for Cancer Biomarkers CCBIO

Collage of photos from CCBIO situations; research, teaching, symposia.

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine, University of Bergen. 

The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. Centre Director is Lars A. Akslen, Department of Clinical Medicine. Read about our research and activities in the CCBIO Annual Report.

Project managers
CCBIO's principal investigators:

next generation immunohistochemistry
Scenes from the symposium. Lecturer and audience.

"Google map" for tumors

The University of Bergen has just implemented the Hyperion Imaging System, next generation immunohistochemistry where researchers can explore tissue biology with 35 antibodies simultaneously. This instrument is the only of its kind in Northern Europe, and is open for booking for all researchers on...

GLOBAL HEALTH PRIORITIES
Ole Frithjof Norheim

Millions to new centre for ethics and priority setting

The research group, Global Health Priorities, has become the research centre BCEPS, thanks to support from Bergen Research Foundation, NORAD, University of Bergen and Bill & Melinda Gates Foundation.

Research support
Kryoimmunterapi-teamet i gang i operasjonssalen.

The Research Council of Norway continues to support next generation cryoimmunotherapy (CryoIT)

The Research Council of Norway has announced that 11 out of 87 received applications have been selected for funding in their programme called "High-quality and Reliable Diagnostics, Treatment and Rehabilitation (BEHANDLING)”. The project “Enhanced cryoimmunotherapy against urogenital cancers”...

Open Access - Plan S
Open Access logo

Norwegian research communities join forces to change new Open Access plan

The Norwegian Research Council and other European research councils are about to make a radical alteration of the scientific publishing model by forcing Open Access for all scientific work. The scheme is called Plan S. 27 Norwegian research leaders, including CCBIO Director Lars A. Akslen, suggest...

Sabbatical report
Front of building

Reflections from sabbatical at Moores Cancer Center, University of California, San Diego

CCBIO Associate Investigator Dana Costea is currently on a sabbatical at Moores Cancer Center at the University of California, San Diego, and reports of a great learning experience on cell signaling and molecular techniques, collaboration strategies and leadership styles, the center’s exemplary way...

Shortcuts: Read CCBIO's Annual Reports and the CCBIO Newsletter

CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.